Brief: Leonabio - Enrolls 500Th Subject In Phase 3 Elaine-3 Trial For Lasofoxifene With Abemaciclib - SEC Filing
26/08/2026 21:45
BRIEF-Leonabio - Enrolls 500Th Subject In Phase 3 Elaine-3 Trial For Lasofoxifene With Abemaciclib - SEC Filing Aug 26 (Reuters) - LeonaBio Inc LONA.O:
LEONABIO - ENROLLS 500TH SUBJECT IN PHASE 3 ELAINE-3 TRIAL FOR LASOFOXIFENE WITH ABEMACICLIB - SEC FILING
Source text: []
Further company coverage: LONA.O
((Reuters.Briefs@thomsonreuters.com;))